Re-evaluation of 400 crimean-congo hemorrhagic fever cases in an endemic area: Is ribavirin treatment suitable?

Vector-Borne and Zoonotic Diseases

Volumn 12, Issue 9, 2012, Pages 812-816

  Duygu, Fazilet ^a   Kaya, Turan ^a   Baysan, Pinar ^b  

^a Tokat State Hospital   (Turkey)

^b Provincial Health Directorate   (Turkey)

Author keywords

CCHFV; Crimean Congo hemorrhagic fever virus

Indexed keywords

RIBAVIRIN;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CRIMEAN CONGO HEMORRHAGIC FEVER; DEMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; ENDEMIC DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM; TURKEY (REPUBLIC);

ADULT; AGED; ALANINE TRANSAMINASE; ANIMALS; ANTIVIRAL AGENTS; ASPARTATE AMINOTRANSFERASES; BLOOD CELL COUNT; ENDEMIC DISEASES; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RIBAVIRIN; TICK BITES; TICKS; TURKEY;

CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; IXODIDA;

EID: 84866268061     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2011.0694     Document Type: Article

References (30)

1. American Society of Health-System Pharmacists. Anti-infective agents. In: Gerald K, ed. American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2003;578-590
2. Andersson I, Bladh L, Mousavi-Jazi M, Magnusson KE, et al. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol 2004; 78:4323-4329. (Pubitemid 38437235)
3. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, et al. Crimean-Congo hemorrhagic fever outbreak in Middle Anatolia: a multicenter study of clinical features and outcome measures. J Med Microbiol 2005; 54:1-5.
4. Cevik, MA, Erbay A, Bodur H, Gü lderen E, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12:374-379.
5. Charrel RN, Attoui H, Butenko AM, Clegg JC, et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 2004; 10:1040-1055. (Pubitemid 40044976)
6. Chiou HE, Liu CL, Buttrey MJ, Kuo HP, et al. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers. Chest 2005; 128:263-272. (Pubitemid 40994483)
7. Drosten C, Minnak D, Emmerich P, Schmitz H, Reinicke T. Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol 2002; 40:1122-1123.
8. Elaldi N, Bodur H. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey J Infect 2009; 58:238-244.
9. Ergonul O, Celikbas A, Dokuzoguz B, Eren S, et al. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy. Clin Infect Dis 2004; 39:284-287. (Pubitemid 38971504)
10. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6:203-214.
11. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antivir Res 2008; 78 125-131.
12. Ertugrul B, Uyar Y. An outbreak of Crimean-Congo hemorrhagic fever in western Anatolia, Turkey. Int J Infect Dis 2009; 13:e431-e436.
13. Frangoulidis D, Meyer H. Measures undertaken in the German Armed Forces Field Hospital deployed in Kosovo to contain a potential outbreak of Crimean-Congo hemorrhagic fever. Mil Med 2005; 170:366-369. (Pubitemid 40656797)
14. Izadi S, Naieni KH, Madjdzadeh SR, Nadim A. Crimean-Congo hemorrhagic fever in Sistan and Baluchestan Province of Iran, a case-control study on epidemiological characteristics. Int J Infect Dis 2004; 8:299-306. (Pubitemid 39119854)
15. Karti SS, Odabasi Z, Korten V, Yilmaz M, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004; 19:1379-1384. (Pubitemid 39014149)
16. Khan AS, Maupin GO, Rollin PE, Noor AM, et al. An outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates, 1994-1995. Am J Trop Med Hyg 1997;57:519-525. (Pubitemid 27500453)
17. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo haemorrhagic fever in Iran. Clin Infect Dis 2003; 36:1613-1618. (Pubitemid 36783348)
18. McCormick JB, King IJ, Webb PA, Scribner CL, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986; 314: 20-26. (Pubitemid 16183064)
19. O'Ergonul, A. Celikbas, N. Baykam, S. Eren and B. Dokuzoguz Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited Clin Microbiol Infect 2006; 12:551-554 (Pubitemid 43740766)
20. Onguru P, Dagdas S. Coagulopathy Parameters in Patients With Crimean-Congo Hemorrhagic Fever and Its Relation With Mortality. Journal of Clinical Laboratory Analysis 2010; 24:163-166
21. Ozkurt Z, Kiki I, Erol S, Erdem F, et al. Crimean-Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. J Infect 2006; 52:207-215. (Pubitemid 43286187)
22. Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 1997; 25:364-367. (Pubitemid 27507306)
23. Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11:794-800.
24. Sweetman SC. Martindale: The Complete Drug Reference, thirtyfourth ed. Great Britain: Pharmaceutical Press, 2005:652-653.
25. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct. 2009; 39:158-160.
26. Tezer H, Sucakli IA, Sayli TR, Celikel E, et al. I Crimean-Congo hemorrhagic fever in children Journal of Clinical Virology 2010; 48:184-186.
27. Tignor GH, Hanham CA. Ribavirin efficacy in an in vivo model of Crimean-Congo haemorrhagic fever virus (CCHF) infection. Antiviral Res 1993; 22:309-325. (Pubitemid 23340819)
28. Vasilenko, SM, Vassilev, TL, Bozadjiev, LG, Bineva, IL, Kazarov, GZ. Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet 1990; 335:791-792. (Pubitemid 20106716)
29. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004; 64:145-160. (Pubitemid 39506835)
30. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March-June 2008. Euro Surveill 2008; 13:189. Available at www.saglik.gov.tr/KKKA/belge/1-6590/kirimkongo- kanamali-atesi-vaka-ve-olumlerin-yillara-html.